The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIOVENTUS | COM CL A | 09075A108 | 74,872,613 | 13,021,324 | SH | SOLE | 13,021,324 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 13,498,233 | 1,551,521 | SH | SOLE | 1,551,521 | 0 | 0 | ||
MEDICINOVA INC | COM NEW | 58468P206 | 1,592,555 | 1,105,941 | SH | SOLE | 1,105,941 | 0 | 0 | ||
MIMEDX GROUP, INC. | COM | 602496101 | 195,393,076 | 28,195,249 | SH | SOLE | 28,195,249 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 1,174,708 | 457,085 | SH | SOLE | 457,085 | 0 | 0 | ||
TELA BIO, INC. | COM | 872381108 | 19,320,332 | 4,110,709 | SH | SOLE | 4,110,709 | 0 | 0 | ||
VENUS CONCEPT, INC. | COM | 92332W204 | 852,836 | 1,089,190 | SH | SOLE | 1,089,190 | 0 | 0 |